WallStreetZenWallStreetZen

NASDAQ: MOR
Morphosys Ag Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsDividendOwnership

Analyst price target for MOR

Based on 1 analyst offering 12 month price targets for Morphosys Ag.
Min Forecast
$15.00+199.4%
Avg Forecast
$15.00+199.4%
Max Forecast
$15.00+199.4%

Should I buy or sell MOR stock?

Based on 1 analyst offering ratings for Morphosys Ag.
Buy
Strong Buy
0 analysts 0%
Buy
1 analysts 100%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their MOR stock forecasts and price targets.

MOR stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
JMP Securities
Bottom 9%
9
BuyMaintains$15.00+199.40%2022-11-18

1 of 1

Forecast return on equity

Is MOR forecast to generate an efficient return?
Company
-46.3%
Industry
10.68%
Market
57.54%
MOR's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is MOR forecast to generate an efficient return on assets?
Company
1.4%
Industry
12.32%
MOR is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

MOR earnings per share forecast

What is MOR's earnings per share in the next 3 years based on estimates from 2 analysts?
Avg 1 year Forecast
-$1.33
Avg 2 year Forecast
-$1.00
Avg 3 year Forecast
$1.18

MOR revenue forecast

What is MOR's revenue in the next 3 years based on estimates from 2 analysts?
Avg 1 year Forecast
$381.0M
Avg 2 year Forecast
$483.9M
Avg 3 year Forecast
$908.3M

MOR vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
MOR$5.01$15.00+199.40%Buy
MCRB$5.50$9.00+63.64%Strong Buy
EWTX$10.75$24.00+123.26%Buy
PSTX$8.03$16.67+107.56%Strong Buy
VKTX$9.10$12.67+39.20%Strong Buy
View Top Biotech Stocks

Morphosys Ag Stock Forecast FAQ

Is Morphosys Ag Stock a good buy in 2023, according to Wall Street analysts?

The consensus among 1 Wall Street analyst covering (NASDAQ: MOR) stock is to Buy MOR stock.

Out of 1 analyst, 0 (0%) are recommending MOR as a Strong Buy, 1 (100%) are recommending MOR as a Buy, 0 (0%) are recommending MOR as a Hold, 0 (0%) are recommending MOR as a Sell, and 0 (0%) are recommending MOR as a Strong Sell.

If you're new to stock investing, here's how to buy Morphosys Ag stock.

What is MOR's earnings growth forecast for 2023-2025?

(NASDAQ: MOR) Morphosys Ag's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 8.5%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 27.25%.

Morphosys Ag's earnings in 2023 is N/A.On average, 2 Wall Street analysts forecast MOR's earnings for 2023 to be -$45,425,899, with the lowest MOR earnings forecast at -$51,915,313, and the highest MOR earnings forecast at -$38,936,485. On average, 2 Wall Street analysts forecast MOR's earnings for 2024 to be -$34,154,811, with the lowest MOR earnings forecast at -$51,915,313, and the highest MOR earnings forecast at -$16,052,761.

In 2025, MOR is forecast to generate $40,302,677 in earnings, with the lowest earnings forecast at $40,302,677 and the highest earnings forecast at $40,302,677.

What is MOR's revenue growth forecast for 2023-2025?

(NASDAQ: MOR) Morphosys Ag's forecast annual revenue growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 64.15%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 11.02%.

Morphosys Ag's revenue in 2023 is N/A.On average, 2 Wall Street analysts forecast MOR's revenue for 2023 to be $13,011,787,573, with the lowest MOR revenue forecast at $12,439,865,262, and the highest MOR revenue forecast at $13,583,709,883. On average, 2 Wall Street analysts forecast MOR's revenue for 2024 to be $16,526,659,173, with the lowest MOR revenue forecast at $15,414,066,204, and the highest MOR revenue forecast at $17,639,252,141.

In 2025, MOR is forecast to generate $31,022,131,735 in revenue, with the lowest revenue forecast at $31,022,131,735 and the highest revenue forecast at $31,022,131,735.

What is MOR's forecast return on assets (ROA) for 2023-2025?

(NASDAQ: MOR) forecast ROA is 1.4%, which is lower than the forecast US Biotechnology industry average of 12.32%.

What is MOR's Price Target?

According to 1 Wall Street analyst that have issued a 1 year MOR price target, the average MOR price target is $15.00, with the highest MOR stock price forecast at $15.00 and the lowest MOR stock price forecast at $15.00.

The Wall Street analyst predicted that Morphosys Ag's share price could reach $15.00 by Nov 18, 2023. The average Morphosys Ag stock price prediction forecasts a potential upside of 199.4% from the current MOR share price of $5.01.

What is MOR's Earnings Per Share (EPS) forecast for 2023-2025?

(NASDAQ: MOR) Morphosys Ag's current Earnings Per Share (EPS) is N/A. On average, analysts forecast that MOR's EPS will be -$1.33 for 2023, with the lowest EPS forecast at -$1.52, and the highest EPS forecast at -$1.14. On average, analysts forecast that MOR's EPS will be -$1.00 for 2024, with the lowest EPS forecast at -$1.52, and the highest EPS forecast at -$0.47. In 2025, MOR's EPS is forecast to hit $1.18 (min: $1.18, max: $1.18).

What is MOR's forecast return on equity (ROE) for 2023-2025?

(NASDAQ: MOR) forecast ROE is -46.3%, which is considered weak.
©2023 WallStreetZen
Company
AboutBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTube
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.